Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Prevention and treatment of violence against women: systematic review and recommendations.

BIBLIOGRAPHIC SOURCE(S)

GUIDELINE STATUS

BRIEF SUMMARY CONTENT

 RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Recommendation grades (A-B-C-D-E-I) are indicated for each recommendation. These definitions are repeated following the recommendations.

Screening

Women: Due to the lack of a demonstrated link between screening and the reduction of violence outcomes, the Canadian Task Force concludes that there is insufficient evidence to recommend for or against routine screening for violence against either pregnant or non-pregnant women (I Recommendation). This is distinct from the need for clinicians to include questions about exposure to domestic violence as part of their diagnostic assessment of women. This information is important in caring for the patient, and may influence assessment and treatment of other health problems.

Men: The Task Force concludes that there is insufficient evidence to recommend for or against primary care screening of men as perpetrators of domestic violence (I Recommendation).

Interventions for Pregnant & Non-Pregnant Women

Primary Care Counseling: The Task Force concludes that there is insufficient evidence to recommend for or against counseling of abused women by primary care clinicians, although decisions to do so may be made by the clinician and patient on other grounds (I Recommendation).

Referral to Shelters: The Task Force concludes that there is insufficient evidence to recommend for or against referral to shelters, although decisions to do so may be made by the clinician and patient on other grounds (I Recommendation).

Referral to Post-Shelter Advocacy Counseling: The Task Force concludes that there is fair evidence (level I, fair) to refer women who have spent at least one night in a shelter to a structured program of advocacy services as outlined in the study by Sullivan & Bybee (Sullivan & Bybee, 1999) (B Recommendation).

Referral to Personal and Vocational Counseling: The Task Force concludes that there is insufficient evidence to recommend for or against referral to personal or vocational counseling, although decisions to do so may be made by the clinician and patient on other grounds (I Recommendation).

Interventions for Men and/or Couples

Batterer/Couples Interventions: The Task Force concludes that there is conflicting evidence regarding the effectiveness of batterer interventions (with or without partner participation) in reducing rates of further domestic violence (Dunford, 2000; Harris et al., 1988; Edelson & Syers, 1991; Brannen & Rubin, 1996; Dutton, 1986; Chen et al., 1989; Palmer et al., 1992; Saunders, 1996; Dobash et al., 1996; Gondolf, 1999; Davis & Taylor, 1999) (C Recommendation).

Grades of Recommendations for Specific Clinical Preventive Actions

A The Canadian Task Force (CTF) concludes that there is good evidence to recommend the clinical preventive action.

B The CTF concludes that there is fair evidence to recommend the clinical preventive action.

C The CTF concludes that the existing evidence is conflicting and does not allow making a recommendation for or use of the clinical preventive action, however other factors may influence decision-making.

D The CTF concludes that there is fair evidence to recommend against the clinical preventive action.

E The CTF concludes that there is good evidence to recommend against the clinical preventive action.

I The CTF concludes that there is insufficient evidence (in quantity and/or quality) to make a recommendation, however other factors may influence decision-making.

The CTF recognizes that in many cases patient specific factors need to be considered and discussed, such as the value the patient places on the clinical preventive action; its possible positive and negative outcomes; and the context and/or personal circumstances of the patient (medical and other). In certain circumstances where the evidence is complex, conflicting or insufficient, a more detailed discussion may be required.

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

REFERENCES SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

Screening

Maneuver: Screening Women (pregnant or non-pregnant)
Level of Evidence:
Studies assessing psychometric properties of tools available, but no studies assessed screening to intervention outcomes.

Maneuver: Screening Men
Level of Evidence:
No studies available

Interventions for Pregnant & Non-Pregnant Women

Maneuver: Primary Care Counseling
Level of Evidence:
No studies available.

Maneuver: Referral to Shelters
Level of Evidence:
No studies available.

Maneuver: Referral to Post-Shelter Advocacy Counseling
Level of Evidence:
Level I, fair

Maneuver: Referral to Personal and Vocational Counseling
Level of Evidence:
No studies available.

Maneuver: Batterer/Couples Interventions
Level of Evidence:
Level 1, good
Levels I, II-1, and II-2 all poor
One fair systematic review

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

ADAPTATION

Not applicable: Guideline was not adapted from another source.

DATE RELEASED

2001 Sep

GUIDELINE DEVELOPER(S)

Canadian Task Force on Preventive Health Care - National Government Agency [Non-U.S.]

SOURCE(S) OF FUNDING

The Canadian Task Force on Preventive Health Care (CTFPHC) is funded through a partnership between the Provincial and Territorial Ministries of Health and Health Canada.

GUIDELINE COMMITTEE

Canadian Task Force on Preventive Health Care (CTFPHC)

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Primary Authors: Harriet L. MacMillan, MD, MSc, FRCPC; C. Nadine Wathen, MA

Members of the Canadian Task Force on Preventive Health Care: John W. Feightner, MD, MSc, FCFP (Chair); Paul Bessette, MD, FRSC(C); R. Wayne Elford, MD, CCFP, FCFP; Denice Feig, MD, MSc, FRCPC; Joanne Langley, MD, MSc, FRCPC; Harriet MacMillan, MD, MSc, FRCPC; Valerie A. Palda, MD, MSc, FRCPC; Christopher Patterson, MD, FRCPC; Bruce Reeder, MD, MHSc, FRCPC

Staff: Nadine Wathen, MA; Ruth Walton, MSc; Jana Fear, BA; Dianne Brooks (Secretary)

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

GUIDELINE AVAILABILITY

Electronic copies: Available from the Canadian Task Force on Preventive Health Care (CTFPHC) Web site.

Print copies: Available from Canadian Task Force on Preventive Health Care, Clinical Skills Building, 2nd Floor, Department of Family Medicine, University of Western Ontario, London, Ontario N6A 5C1, Canada.

AVAILABILITY OF COMPANION DOCUMENTS

The following are available:

PATIENT RESOURCES

None available

NGC STATUS

This summary was completed by ECRI on August 20, 2003. The information was verified by the guideline developer on September 18, 2003.

COPYRIGHT STATEMENT

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo